Skip to main content
  • Bempedoic Acid Comparable to Statins in Lowering Cholesterol and MACE Risk: CLEAR Outcomes Analysis

    The use of bempedoic acid to lower low-density lipoprotein cholesterol (LDL-C) is similar to that of statin use, as a new prespecified analysis outlines the therapy’s role in reducing the risk of major adverse cardiovascular events (MACE).

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details